IMMUNOPHENOTYPE OF SOLID TUMORS AND TUMOR METABOLIC REPROGRAMMING
Files
(Embargo until 2026-06-24)
(Embargo until 2026-06-24)
(Embargo until 2026-06-24)
Date
2024
Authors
Contributor
Advisor
Department
Instructor
Depositor
Speaker
Researcher
Consultant
Interviewer
Narrator
Transcriber
Annotator
Journal Title
Journal ISSN
Volume Title
Publisher
Volume
Number/Issue
Starting Page
Ending Page
Alternative Title
Abstract
ABSTRACTWith the technological advances in biotechnology that have been made high-throughput measurement
of nucleic acids feasible and affordable, the tumor microenvironment (TME) has been intensively
studied. Advances in therapy have made pharmacologic treatment of cancer more effective than ever
before. However, in consideration of the expense of the new class of monoclonal immunotherapeutic
antibodies, their occasionally serious side effect profile, and a somewhat limited spectrum of activity
among patient cohorts, there has come a great demand to understand the factors which make
individual cases of cancer differ. Many approaches to address the issue of individual patient response to
immunomodulatory antibodies have been devised. Both traditional, bench-based approaches and more
modern, bioinformatical solutions have yielded important insights into the problem. Unfortunately,
many difficult and important questions have remained unexplained. In particular, a general theory that
is capable of explaining the broadest similarity of observed clinical responses to therapy with
monoclonal immunotherapeutic agents across dissimilar patient cohorts that identifies a clear
relationship to cellular and molecular features has been elusive. Understanding the most important
concepts involved in tumor immunology requires drawing together some intermediate and detailed
knowledge from several subdisciplines in biology and clinical medicine. In the studies presented here,
elements of bioinformatic data analysis, details of immunological function, and knowledge of cellular
and molecular processes relevant to cancer are reviewed in terms of published literature as an
introduction. In a second segment, these topics of perceived relevance to studies of cancer are then
highlighted with presentations of new findings based upon a novel bioinformatic approach. A summary
is presented in Chapter 3 containing a brief discussion of how these findings impact the field with
reference to current knowledge and practice, while a series of Appendices further substantiate the
importance of these findings with brief details of a variety of related results.
Description
Keywords
Medicine, Immunology, Bioinformatics, bioinformatics, biologic therapies, immunophenotype, molecular diagnostics, pan-cancer, tumor immunology
Citation
Extent
201 pages
Format
Geographic Location
Time Period
Related To
Related To (URI)
Table of Contents
Rights
All UHM dissertations and theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission from the copyright owner.
Rights Holder
Local Contexts
Email libraryada-l@lists.hawaii.edu if you need this content in ADA-compliant format.